138865-41-5

Basic information

• Product Name: Naphthalene, 1-broMo-4-(phenylMethoxy)-
• Synonyms: Naphthalene, 1-broMo-4-(phenylMethoxy)-;1-Bromo-4-(phenylmethoxy)-naphthalene
• CAS NO: 138865-41-5
• Molecular Formula: C₁₇H₁₃BrO
• Molecular Weight: 313.18852
• Mol File: 138865-41-5.mol
• Article Data: 11

Chemical Properties

• Melting Point: 77-80 °C
• Boiling Point: 435.2±20.0 °C(Predicted)
• Appearance: /
• Density: 1.395±0.06 g/cm3(Predicted)
• CAS DataBase Reference: Naphthalene, 1-broMo-4-(phenylMethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: Naphthalene, 1-broMo-4-(phenylMethoxy)-(138865-41-5)
• EPA Substance Registry System: Naphthalene, 1-broMo-4-(phenylMethoxy)-(138865-41-5)

Safety Data

• Hazardous Substances Data: 138865-41-5(Hazardous Substances Data)

Upstream product

• 571-57-3 4-bromo-1-naphthol 
• 100-44-7 benzyl chloride 
• 100-39-0 benzyl bromide 
• 607-58-9 1-(phenylmethoxy)naphthalene 
• 620-05-3 iodomethylbenzene 
• 90-15-3 α-naphthol 

Downstream Products

• 87344-63-6 4-benzyloxy-1-naphthoic acid 
• 1379588-81-4 C₁₈H₁₄OS₂ 
• 1379588-87-0 C₂₅H₁₇NOS₃ 
• 1379588-93-8 C₂₄H₂₅NO₃S 
• 1379588-99-4 C₂₃H₂₃NO₃S 
• 183170-90-3 1-benzyloxynaphthalene-4-boronic acid 
• 1374750-76-1 1-benzyloxy-4-(2-hydroxy-2-adamantyl)naphthalene 
• 221087-65-6 2-(2,5-dimethylpyrrolyl)-6-(4-benzyloxy-1-naphthyl)pyridine 
• 865360-02-7 3-(4-benzyloxy-1-naphthoyl)-1-(N-methylpiperidin-2-ylmethyl)indole 
• 136593-80-1 4-benzyloxy-1-naphthoic acid chloride 

Relevant articles and documents

RNAI AGENTS FOR INHIBITING EXPRESSION OF BETA-ENAC, COMPOSITIONS THEREOF, AND METHODS OF USE

Described are RNAi agents, compositions that include RNAi agents, and methods for inhibition of a beta-ENaC (SCNN1B) gene. The beta-ENaC RNAi agents and RNAi agent conjugates disclosed herein inhibit the expression of a beta-ENaC gene. Pharmaceutical comp

ANTICANCER COMPOUNDS

The present invention discloses compounds for inhibition of uncontrolled cell proliferation particularly in cancer stem cells. Particularly, the invention relates to compounds of Formula III to XIV for the treatment of cancer, such as breast and prostate cancer.

NOVEL PHENYLNAPHTHOL DERIVATIVES

Phenylnaphthol derivatives represented by the following general formula (1), wherein, R1 to R3 are hydrogen atoms, alkyl groups or aryl groups, and R2 and R3 may be bonded together to form an aliphatic hydrocarbon ring or a heterocyclic ring, a and b are, respectively, integers of 0 to 4, R4 and R5 are hydroxyl groups, alkyl groups, haloalkyl groups, cycloalkyl groups, alkoxy groups, amino groups, heterocyclic groups having a nitrogen atom as a hetero atom and are bonded together via the nitrogen atom, cyano groups, nitro groups, formyl groups, hydroxycarbonyl groups, alkylcarbonyl groups, alkoxycarbonyl groups, halogen atoms, aralkyl groups, aralkoxy groups, aryloxy groups, aryl groups, heteroaryl groups bonded together via a carbon atom in the ring, alkylthio groups, cycloalkylthio groups, arylthio groups or heteroarylthio groups, and if R4 or R5 are present in a plural number, the plurality of R4 or the plurality of R5 may be the same or different, or 2 R4s or 2 R5s may be bonded together to form an alicyclic hydrocarbon ring or a heterocyclic ring. The compounds are useful as intermediate products for the synthesis of, for example, photochromic compounds.